AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines HONG KONG, March 10, 2025 /PRNewswire/ — AIM Vaccine Co., Ltd. (06660.HK),… CISION PRNewswireMarch 10, 2025
Press ReleaseU.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR® OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the… CISION PRNewswireMarch 10, 2025
Press ReleaseAppian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience SYDNEY, March 10, 2025 /PRNewswire/ — Appian (NASDAQ: APPN) today announced the… CISION PRNewswireMarch 10, 2025
Press ReleaseHKA WELCOMES FORENSIC ACCOUNTING EXPERT JACQUELINE WOODS TO HKA IN AUSTRALIA SYDNEY, March 10, 2025 /PRNewswire/ — HKA, a leading global consultancy in… CISION PRNewswireMarch 10, 2025
Press ReleaseAeroband Hits the Right Note at SXSW: The Best Smart Musical Instrument Brand Inspiring the Future of Music Unleash the Rhythm of Inspiration at SXSW with Aeroband AUSTIN, Texas, March… CISION PRNewswireMarch 9, 2025
Global Times: Up Close: President Xi joins national political advisors in education discussion BEIJING, March 9, 2025 /PRNewswire/ — Chinese President Xi Jinping, also general secretary… CISION PRNewswireMarch 9, 2025
China's unwavering opening-up efforts unlock global opportunities BEIJING, March 9, 2025 /PRNewswire/ — A report from People’s Daily: China… CISION PRNewswireMarch 9, 2025
China's regional powerhouses chart distinctive paths in national modernization drive BEIJING, March 9, 2025 /PRNewswire/ — A report by People’s Daily ：… CISION PRNewswireMarch 9, 2025
